2020 Annual Meeting | P13 - Poster Session 13

Date Wednesday 04/29/20

Time 05:30 PM - 06:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG), Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis

CME Available 0.00 credit

Event Timeline
05:30 PM - 06:30 PM	Abstract	9-001 - Cladribine Decreases CD95-expressing CD4+ and CD8+ Cells in Lymphoid Organs in Naïve Marmosets (Callithrix Jacchus)
05:30 PM - 06:30 PM	Abstract	9-002 - Long-term Efficacy of Cladribine Tablets in Patients with Relapsing-Remitting or Secondary Progressive Multiple Sclerosis: Analysis of Real World Data From the Italian Multiple Sclerosis Registry (CLARINET-MS) Francesco Patti, MD
05:30 PM - 06:30 PM	Abstract	9-003 - Adult-Onset Recurrent Fulminant Acute Disseminated Encephalomyelitis (ADEM) Requiring Hemicraniectomy – A Case Report Maria Antonietta Mazzola, MD
05:30 PM - 06:30 PM	Abstract	9-004 - Year 1 Performance of Adveva®, a Patient Support Program (PSP) for Patients Taking MAVENCLAD® (cladribine tablets) for Highly Active Relapsing Remitting Multiple Sclerosis (RRMS) in United Kingdom (UK)
05:30 PM - 06:30 PM	Abstract	9-005 - A Real-World Retrospective Analysis of Outcomes in Multiple Sclerosis Patients Who Transitioned to Alemtuzumab After Rituximab or Ocrelizumab Marie Coste
05:30 PM - 06:30 PM	Abstract	9-006 - The patients´ perspective in multiple sclerosis: the SymptoMScreen questionnaire correlates with clinical characteristics and clinician-assessed outcomes Jorge Maurino
05:30 PM - 06:30 PM	Abstract	9-007 - Pharmacodynamic Biomarkers of Interferon ß-1a: Assessment in Patients Receiving Long-Term Treatment with Subcutaneous Interferon ß-1a Mark S. Freedman, MD, F�鶹��ýӳ��
05:30 PM - 06:30 PM	Abstract	9-009 - Baseline Patient and Caregiver Characteristics From a Prospective, Noninterventional, Real-World Study (REALITY) on the Effect of Alemtuzumab on Fatigue and Other Patient- and Caregiver-Reported Quality-of-Life Outcomes in Patients With RRMS
05:30 PM - 06:30 PM	Abstract	9-010 - Which Brain Lesion Locations Differentiate Multiple Sclerosis (MS) from Neuromyelitis Optica Spectrum Disorders (NMOSD) and MOG Antibody Disorder (MOGAD)? Jasmin Patel, MD
05:30 PM - 06:30 PM	Abstract	9-011 - A Rare Case of Balos Concentric Sclerosis (BCS) in a Patient with Multiple Sclerosis (MS) Bradley Shane, MD
05:30 PM - 06:30 PM	Abstract	9-012 - Atypical myelitis in patients with multiple sclerosis: characterization and comparison with typical multiple sclerosis and neuromyelitis optica spectrum disorders Kevin Bigaut
05:30 PM - 06:30 PM	Abstract	9-013 - Two Cases with Acute Tumefactive non enhancing Demyelinating lesions; The Significance of Gadolinium Contrast enhancement in MRI Faisal A. Ibrahim, MD
05:30 PM - 06:30 PM	Abstract	9-014 - A 2-year Study to Evaluate the Onset of Action of Cladribine Tablets in Subjects with Highly Active Relapsing Multiple Sclerosis: Results from MAGNIFY-MS Baseline Analysis Nicola De Stefano, MD
05:30 PM - 06:30 PM	Abstract	9-015 - Siponimod Penetrates, Distributes and Acts on the Central Nervous System: Translational Insights Marc Bigaud
05:30 PM - 06:30 PM	Abstract	9-016 - Improving individualized monitoring strategy for Rituximab treatment in patients with Neuromyelitis Optica Spectrum Disorders: development of a high sensitive ddPCR assay for CD19 mRNA quantification. Antonio Bertolotto, MD, F�鶹��ýӳ��
05:30 PM - 06:30 PM	Abstract	9-017 - Risk Stratification for Demyelinating Disease Secondary to TNF-Alpha Inhibitor Exposure Amy W. Laitinen, MD
05:30 PM - 06:30 PM	Abstract	9-018 - Functional Outcomes Differ Between Vascular and Inflammatory Myelopathies Maria A. Garcia-Dominguez, MD
05:30 PM - 06:30 PM	Abstract	9-019 - White Matter Myelin Alterations are Diffuse in Neuromyelitis Optica Spectrum Disorders and Prevail on Axonal Damage Laura Cacciaguerra, MD, PhD
05:30 PM - 06:30 PM	Abstract	9-020 - Cladribine supresses the activity of neuromyelitis optica: two year follow up study Konrad Rejdak, PhD
05:30 PM - 06:30 PM	Abstract	9-021 - A Rare Presentation of Biopsy-Proven Necrotizing Neurosarcoidosis in a Woman with Exposure to MDR-TB John Peters, MD
05:30 PM - 06:30 PM	Abstract	9-022 - Serum biomarkers and patient age in multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders Eun-Jae Lee, MD, PhD
05:30 PM - 06:30 PM	Abstract	15-001 - Increased Likelihood of Relapse in Pediatric Anti-MOG Acute Disseminated Encephalomyelitis (ADEM) and Optic Neuritis (ON) vs. Seronegative ADEM and ON Patients Kristen Fisher, DO
05:30 PM - 06:30 PM	Abstract	15-002 - Optic Chiasm Involvement Associated with Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies Deena Tajfirouz, MD
05:30 PM - 06:30 PM	Abstract	15-003 - Clinical Phenotypes, Predictors of Relapse, and Response to Treatment in Myelin Oligodendrocyte Glycoprotein-Antibody Associated Disorders Wendy S. Vargas, MD
05:30 PM - 06:30 PM	Abstract	15-004 - Treatment Strategies in anti-myelin oligodendrocyte glycoprotein (MOG) associated Demyelinating Disease in a Pediatric Cohort Anita M. Fletcher, MD
05:30 PM - 06:30 PM	Abstract	15-005 - Myelin oligodendrocyte glycoprotein (MOG) antibodies: results from first 1,045 specimens tested at a clinical reference laboratory Sat Dev Batish, PhD, F�鶹��ýӳ��
05:30 PM - 06:30 PM	Abstract	15-006 - Neuromyelitis Optica Spectrum Disorders and Systemic Lupus Erythematosus: Case Series from an University Center Vanessa C. Colares Lessa, MD
05:30 PM - 06:30 PM	Abstract	15-007 - Neuromyelitis Optica Spectrum Disorder (NMOSD) Misdiagnosed as Spinal Cord Infarction Odai Abdalla, MBBS
05:30 PM - 06:30 PM	Abstract	15-008 - Adding FUEL to the FLAMES: FLAIR-variable Unilateral Enhancement of the Leptomeninges (FUEL) in MOG-IgG-Associated Disease Adrian Budhram, MD
05:30 PM - 06:30 PM	Abstract	15-009 - Anti-MOG Antibody associated Encephalomyelitis in an HIV-Positive Patient Karissa Arca, MD
05:30 PM - 06:30 PM	Abstract	15-010 - Autologous haematopoietic stem cell transplantation in multiple sclerosis and other immune-mediated neurological diseases: guidelines and recommendations of the European Society for Blood and Marrow Transplantation and the Joint Accreditation Committee of the International Society for Cellular Therapy Basil Sharrack, MD, PhD, F�鶹��ýӳ��
05:30 PM - 06:30 PM	Abstract	15-011 - Clinical Course and Treatment Response in a Cohort of Pediatric Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Xinran Xiang, MD
05:30 PM - 06:30 PM	Abstract	3-001 - A Case of Two Brothers: Should we look beyond a Cerebral Palsy diagnosis? Ihedinachi Ndukwe, MD
05:30 PM - 06:30 PM	Abstract	3-002 - A Case Report of Two Siblings Aicardi-Goutières Syndrome Type 2
05:30 PM - 06:30 PM	Abstract	3-003 - The association of gender, age of onset and phenotype in Functional Movement Disorders: The FMD-GAP Study Sarah C. Lidstone, MD, PhD
05:30 PM - 06:30 PM	Abstract	3-004 - Quantitative oculomotor assessment in X-linked dystonia parkinsonism: a potential motor biomarker Christopher D. Stephen, MB ChB, FRCP, MSc, SM
05:30 PM - 06:30 PM	Abstract	3-005 - Treatment of Paroxysmal Kinesigenic Dyskinesia With Use of Low Dose Oxcarbazepine: Experience at a Pediatric Tertiary Care Center. Mariam Hull, MD
05:30 PM - 06:30 PM	Abstract	3-006 - A Novel SPAST/SPG4 Splice-Site Mutation in a Family with Dominant Hereditary Spastic Paraplegia Nathaniel M. Robbins, MD
05:30 PM - 06:30 PM	Abstract	3-007 - Newly Identified Dynactin Variant (DCTN1 p.Tyr78His) in a Patient with Perry Syndrome Marek Cierny, MD
05:30 PM - 06:30 PM	Abstract	3-008 - SANDO Syndrome associated with new POLG heterozygous gene mutation: Case Report. Daniel A. Crespo, MD
05:30 PM - 06:30 PM	Abstract	3-009 - Testing a Potential Marker for the Diagnosis of Functional Movement Disorders Jessica Tom
05:30 PM - 06:30 PM	Abstract	3-010 - An Unusual Case of Untreated Galactosemia in an Adult Woman Keith Groshans, MD
05:30 PM - 06:30 PM	Abstract	3-011 - Acute Onset Chorea in Profound Hypophosphatemia with Bilateral Basal Ganglia Lesions Chaitanya Medicherla, MD
05:30 PM - 06:30 PM	Abstract	3-012 - Mass Media and Mass Psychogenic Illness Jennifer W. McVige, MD, F�鶹��ýӳ��
05:30 PM - 06:30 PM	Abstract	3-013 - A Comparison of FND Diagnostic Criteria: Retrospective Chart Review Kevin J. Kyle, MD
05:30 PM - 06:30 PM	Abstract	3-014 - Characterization of a large retrospective cohort of functional movement disorders patients from the University of Colorado Health system Zachary Macchi, MD
05:30 PM - 06:30 PM	Abstract	3-015 - Correlation Between Dysautonomic Symptoms and Severity in Patients with Hereditary Spastic Paraplegia
05:30 PM - 06:30 PM	Abstract	3-016 - Partial Stiff Person Syndrome as a Stroke Mimic Duarte G. Machado, MD, F�鶹��ýӳ��
05:30 PM - 06:30 PM	Abstract	3-017 - Effects of ATP1A3 Mutations on Brain Functional Network Connectivity Christopher T. Whitlow, MD
05:30 PM - 06:30 PM	Abstract	12-001 - Incidence of Leukopenia in Ketogenic diet: A single-center experience
05:30 PM - 06:30 PM	Abstract	12-002 - Effect of Ketogenic Diet on Serum Levels of Interleukin-6 and Interleukin-1ß in Pediatric Patients with Drug-resistant Epilepsy
05:30 PM - 06:30 PM	Abstract	12-003 - Hyperperfusion in the cerebellum in patients with epileptic seizures Masako Kinoshita, MD, PhD
05:30 PM - 06:30 PM	Abstract	12-004 - Perampanel May Improve Insomnia Through a Decrease in Anxiety in Patients with Epilepsy Mina Jung, MD
05:30 PM - 06:30 PM	Abstract	12-005 - Post Hoc Univariate and Multivariate Analyses to Identify Clinical Factors Associated with a 50% or 75% Response in a Phase III Trial of Adjunctive Perampanel in Patients with Primary Generalized Tonic-Clonic Seizures (PGTCS) Christian Brandt, MD
05:30 PM - 06:30 PM	Abstract	12-006 - Efficacy and Safety of Adjunctive Perampanel 4 mg/day in Pediatric Patients (Aged 4 to <12 Years) with Partial-Onset Seizures (POS) or Primary Generalized Tonic-Clonic Seizures (PGTCS) in Study 311 Katherine Moretz, MD
05:30 PM - 06:30 PM	Abstract	12-007 - Perampanel Exposure–Response Relationships for Cognition and Safety in Pediatric Patients (Aged 4 to <12 years) with Epilepsy
05:30 PM - 06:30 PM	Abstract	12-008 - Pharmacokinetic and Food Effect Assessment of XEN496 (Pediatric Formulation of Ezogabine) in Healthy Adults and Relative Bioavailability Assessment with Potiga® (Adult Formulation of Ezogabine)
05:30 PM - 06:30 PM	Abstract	12-009 - Development of Pediatric Formulations of the Potassium Channel Opener Ezogabine and the NaV1.6-Selective Sodium Channel Blocker XEN901 for the Treatment of Developmental and Epileptic Encephalopathies
05:30 PM - 06:30 PM	Abstract	12-010 - Efficacy and Safety of Eslicarbazepine Acetate According to Epilepsy Etiology: A Post-hoc Analysis of Three Phase III Trials in Adults with Focal Seizures David Cantu, PhD
05:30 PM - 06:30 PM	Abstract	6-001 - An Interesting twist in the diagnosis of intracranial lesions in an immunocompromised patient Aparna M. Prabhu, MD
05:30 PM - 06:30 PM	Abstract	6-002 - Dysphagia as the Initial Presentation of Varicella Zoster Virus Meningitis: A Case Report Daniel M. Oh, MD
05:30 PM - 06:30 PM	Abstract	6-003 - A Thoracentesis with a Neurological Surprise Sakinah Sabadia, MD
05:30 PM - 06:30 PM	Abstract	6-004 - Uhthoff’s Phenomenon in Amyotrophic Lateral Sclerosis
05:30 PM - 06:30 PM	Abstract	6-005 - Prominent Corticospinal Tract Changes on MRI in Bulbar Onset Amyotrophic Lateral Sclerosis (ALS) Derek G. Neupert, MD
05:30 PM - 06:30 PM	Abstract	6-006 - Longitudinal bulbar and respiratory declines in Amyotrophic Lateral Sclerosis (ALS) Nnenna Asidianya
05:30 PM - 06:30 PM	Abstract	6-007 - Ataxia and ophthalmoplegia: an atypical case of Miller Fisher Syndrome (MFS) with anti-GAD antibody Ali R. Shoraka, MD
05:30 PM - 06:30 PM	Abstract	6-008 - PET Imaging in Rapidly Progressive Neurodegeneration – an Underutilised Resource? Michael Doyle, MRCPI
05:30 PM - 06:30 PM	Abstract	6-009 - Muscle Satellite Cell Ablation Leads to Disorganization of Muscle Microvasculature Kyutae Kim
05:30 PM - 06:30 PM	Abstract	6-010 - Serum Neurofilament Light Chain Concentrations Withstand Delayed Freezing up to 24 Hours – a Pre-analytical Study. Patrick Altmann
05:30 PM - 06:30 PM	Abstract	6-011 - No Need for Netflix; TV Rerun Syndrome: The Result of Concurrent Déjà vécu And Hyperfamiliarity for Faces
05:30 PM - 06:30 PM	Abstract	7-001 - Migraine-related disability and co-morbid depression among migraineurs in Ethiopia: a cross-sectional study Biniyam A. Ayele, MBBS
05:30 PM - 06:30 PM	Abstract	7-002 - CGRP, PACAP, and VIP serum Levels in Chronic Migraine: are they Usefull in Clinical Practice? A Case-Control Study Agustin Oterino Duran, MD
05:30 PM - 06:30 PM	Abstract	7-003 - Development of a Novel Drug for the Prevention of Migraine based on Receptor Activity Mapping and Achievement of a Target Receptor Profile
05:30 PM - 06:30 PM	Abstract	7-004 - Phase 1 and 2 Safety, Tolerability and Pharmacokinetics of Single and Multiple Dose Rimegepant as Compared to the Predicted Clinically Efficacious Dose Range Charlie Conway
05:30 PM - 06:30 PM	Abstract	7-005 - Temporalis muscle thickness as surrogate marker of activation of motor component of trigemino-vascular system in Migraine patients Amit S. Singh, MD
05:30 PM - 06:30 PM	Abstract	7-006 - Novel Receptor Activity Mapping of Methysergide and its Metabolite, Methylergometrine, Provides a Mechanistic Rationale for both the Clinically Observed Efficacy and Risk of Fibrosis in Patients with Migraine
05:30 PM - 06:30 PM	Abstract	7-007 - Neural Correlates of Visuospatial Processing in Migraine Patients: Does the Pain Network Interfere? Roberta Messina, MD, PhD
05:30 PM - 06:30 PM	Abstract	7-008 - MRI findings in Neurosarcoidosis Patients with Headache as a Primary Presenting Symptom Yamin Sallowm, MD
05:30 PM - 06:30 PM	Abstract	7-009 - Variables Affecting Rates of Neuroimaging and Referral for Headache Katherine L. Berry, MD
05:30 PM - 06:30 PM	Abstract	7-010 - A Design Framework for the Creation of a User-centered Headache Diary App Through a Qualitative Analysis of App Reviews
05:30 PM - 06:30 PM	Abstract	1-001 - Atypical CISP: A New Variant of Chronic Immune Sensory Demyelinating Polyradiculoneuropathy
05:30 PM - 06:30 PM	Abstract	1-002 - Skin Biopsy as a Biomarker in Chronic Inflammatory Demyelinating Polyneuropathy Fatma Yesim Parman, MD
05:30 PM - 06:30 PM	Abstract	1-003 - Health Utilities and Acceptable States in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) – Preliminary data
05:30 PM - 06:30 PM	Abstract	1-004 - Triggers and Risk Factors in Lumbosacral Radiculoplexus Neuropathy Marcus Vinicius R. Pinto, MD
05:30 PM - 06:30 PM	Abstract	1-005 - Subcutaneous Immunoglobulin (SCIG) Therapy for Neuromuscular Conditions; A KU Experience Chaitanya Amrutkar, MD
05:30 PM - 06:30 PM	Abstract	1-006 - Vasculitic Neuropathy in a Patient with IgG4-related Disease Benjamin Jiang, MD
05:30 PM - 06:30 PM	Abstract	1-007 - Acute polyradiculoneuropathy due to small molecule protein kinase inhibitors in cancer treatment Sara J. Doyle, MD
05:30 PM - 06:30 PM	Abstract	1-008 - Population Characteristics and Progression to Disability Among Patients with Small Fiber Neuropathy Stephen A. Johnson, MD
05:30 PM - 06:30 PM	Abstract	1-009 - Combined central and peripheral demyelination: a case serie Nicolas Dubuisson, MD
05:30 PM - 06:30 PM	Abstract	1-010 - Diagnostic Criteria for Idiopathic Distal Sensory Polyneuropathy and Idiopathic Small Fiber Polyneuropathy Roy L. Freeman, MD
05:30 PM - 06:30 PM	Abstract	1-011 - Analysis Of Clinical Symptomatology In Patients With TS- HDS Polyneuropathy Via Clinical Questionnaire Sri Raghav S. Sista, MD
05:30 PM - 06:30 PM	Abstract	1-012 - Phrenic Neuropathy Water Immersion Dyspnea: Clinical Findings and Need for Patient Counseling Rocio Vazquez Do Campo, MD
05:30 PM - 06:30 PM	Abstract	1-013 - Hereditary Transthyretin Amyloidosis and Carpal Tunnel Syndrome: Update on Opportunities for Earlier Diagnosis of Amyloidosis Shivkumar Bhadola, MD
05:30 PM - 06:30 PM	Abstract	1-014 - Rationale and Design of NEURO-TTRansform, a Phase 3 Study to Evaluate the Efficacy and Safety of AKCEA-TTR-LRx (ION-682884) in Patients with Hereditary Transthyretin-Mediated Amyloid Polyneuropathy Cecilia Monteiro, MD, PhD
05:30 PM - 06:30 PM	Abstract	10-001 - Determinants of aphasia recovery in early post-stroke phase: Exploratory use of decision tree analysis Durjoy Lahiri, MD, DM
05:30 PM - 06:30 PM	Abstract	10-002 - Implicit identification of disability in right brain stroke survivors. A. M. Barrett, MD, F�鶹��ýӳ��
05:30 PM - 06:30 PM	Abstract	10-003 - Association of Stroke Health Literacy with Stroke Risk Factors and Post- Stroke Depression
05:30 PM - 06:30 PM	Abstract	10-004 - Transient global amnesia is related to aberrant higher functional activity in the salience network and lower functional activities in the default mode network Seung-Ah Lee
05:30 PM - 06:30 PM	Abstract	10-005 - Chronotaraxis: An Underestimated Right Hemisphere Syndrome Michael Hoffmann, MD, FCP, FAHA, F�鶹��ýӳ��
05:30 PM - 06:30 PM	Abstract	10-006 - Fregoli Delusion: A disorder of Misidentification with Temporal Lobe Metastasis Secondary to Lung Carcinoma
05:30 PM - 06:30 PM	Abstract	10-007 - Capgras syndrome in a 21-year-old patient with a chondrosarcoma compressing the right temporal lobe Jodi Nelson, DO
05:30 PM - 06:30 PM	Abstract	10-008 - Witzelsucht or Compulsive Joking and Loss of the Right Frontal Lobe Leila Parand, MD
05:30 PM - 06:30 PM	Abstract	10-009 - A Surgically Treated Case of Partial Kluver-Bucy Syndrome Avalon O'Connor
05:30 PM - 06:30 PM	Abstract	10-010 - Intracranial solitary fibrous tumor presenting as Gerstmann syndrome: A double rarity!
05:30 PM - 06:30 PM	Abstract	10-011 - From Kid to K-9: A Case of Benzodiazepine Withdrawal-Induced Zoopsic Intermetamorphosis Hoda Seens, MD
05:30 PM - 06:30 PM	Abstract	4-001 - The Oldest Bleeds in the Oldest State: Hemorrhagic Stroke in the Nonagenarian Population Robert G. Michaud, Jr.
05:30 PM - 06:30 PM	Abstract	4-002 - National Estimates Of Recurrent Intracranial Hemorrhage Among Patients With Ruptured Intracranial Aneurysms
05:30 PM - 06:30 PM	Abstract	4-003 - The impact of obstructive sleep apnea on ruptured intracranial aneurysm Shyamal C. Bir, MD
05:30 PM - 06:30 PM	Abstract	4-004 - Acute Multifocal Atraumatic Convexity Subarachnoid Hemorrhage Katarina B. Dakay, DO
05:30 PM - 06:30 PM	Abstract	4-005 - Incidence and Significance of EEG Abnormalities in Atraumatic Convexity Subarachnoid Hemorrhage Katarina B. Dakay, DO
05:30 PM - 06:30 PM	Abstract	4-006 - A Case of Early Rupture Following Flow-Diversion with Quantification of Hemodynamics and Aneurysmal Wall Stress using Additive Manufacturing and Particle Tracking Velocimetry Melissa Cook, MD
05:30 PM - 06:30 PM	Abstract	4-007 - Prognosis on Admission of Aneurysmal Subarachnoid Hemorrhage (PAASH) scale validation in Mexican Population Raul Anwar Garcia Santos, MD
05:30 PM - 06:30 PM	Abstract	4-008 - Intraventricular and Intravenous Milrinone for Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage Naresh Mullaguri, MD
05:30 PM - 06:30 PM	Abstract	4-009 - Aneurysmal subarachnoid hemorrhage: frequency and clinical evolution according to aneurysmal size Mario E. Ricciardi, Sr., MD
05:30 PM - 06:30 PM	Abstract	4-010 - National Estimates Of Recurrent Intracranial Hemorrhage Among Patients With Unruptured Intracranial Aneurysms: Effect Of Treatment Modality
05:30 PM - 06:30 PM	Abstract	4-011 - Use of Pipeline Flow Diversion in Acute Ruptured Fusiform Anterior Cerebral Artery Aneurysm Yahia M. Lodi, MD, F�鶹��ýӳ��
05:30 PM - 06:30 PM	Abstract	4-012 - Hemodynamic Alterations and Reversible Cervicomedullary Edema after Embolization of Cranial Dural Arteriovenous Fistula Jessica White, MD
05:30 PM - 06:30 PM	Abstract	4-013 - Case Report of an Acute Progressive Spinal Dural Arteriovenous Fistula after Multiple Prolonged Flights Shirley Ju, MD
05:30 PM - 06:30 PM	Abstract	4-014 - Endovascular Reconstruction Utilizing Flow Diversion Stenting in a Patient with Bilateral Giant Cavernous Internal Carotid Artery Aneurysms Keithan Sivakumar, MD
05:30 PM - 06:30 PM	Abstract	4-015 - Exceptional case of rapid growth and ruptured of a very small asymptomatic unruptured intracranial aneurysm which was stable over years in a 72 years old active smoker Yahia M. Lodi, MD, F�鶹��ýӳ��
05:30 PM - 06:30 PM	Abstract	4-016 - A Teenager with a Peridural Ring Giant Supraclinoid Aneurysm Franklyn Rocha Cabrero, MD
05:30 PM - 06:30 PM	Abstract	4-017 - Rapid Onset Cognitive Impairment and Unusual Bithalamic Lesions Conrad J. Goerz, MD
05:30 PM - 06:30 PM	Abstract	4-018 - Ruptured Spinal Aneurysm as a Complication of Post-Partum Angiopathy Ahmad Nehme, MD
05:30 PM - 06:30 PM	Abstract	4-019 - Flow-Diverting Stent Placement in a Pediatric Patient Through Radial Artery Approach Ivo Bach, MD
05:30 PM - 06:30 PM	Abstract	4-020 - Multiple watershed infarcts confirming the existence of a vascular steal phenomenon established around a brain arteriovenous malformation Gabriel Torrealba Acosta, MD
05:30 PM - 06:30 PM	Abstract	4-021 - Headache at Onset of Intracerebral Hemorrhage and Associations with Outcome Michael Reznik, MD
05:30 PM - 06:30 PM	Abstract	13-001 - Lyme Neuroborreliosis presenting as multiple bilateral cranial nerve palsies Spurthi Surpur, MD
05:30 PM - 06:30 PM	Abstract	13-002 - The Great Mimicker: A Case of Bannwarth Syndrome Bindi A. Nia, DO
05:30 PM - 06:30 PM	Abstract	13-003 - Lyme Neuroborreliosis Presenting with a Cytotoxic Lesion of the Corpus Callosum, Diffuse Cerebral Edema, and Multifocal Infarcts Benjamin Jiang, MD
05:30 PM - 06:30 PM	Abstract	13-004 - Nocardiosis of the Central Nervous System: Brain MR Imaging Finding And Outcome with review of the literature Waad Alshammari, MBBS
05:30 PM - 06:30 PM	Abstract	13-005 - Combined Capnocytophaga spp. and Fusobacterium Nucleatum Brain Abscess with Vibrio Cholera Infection: a Case Report Alexander J. Senetar, DO
05:30 PM - 06:30 PM	Abstract	13-006 - Skipped Multilevel Lesion as An Atypical Tuberculous Spondylitis Mimicking Spinal Metastasis: Case Report Paulus Sugianto, MD, F�鶹��ýӳ��
05:30 PM - 06:30 PM	Abstract	13-007 - Encephalitis By Bartonella Quintana, A Rare Entity In The Pediatric Age
05:30 PM - 06:30 PM	Abstract	13-008 - Sensorineural Hearing Loss as an Atypical Presentation of Typhoid Fever in Adult Patient Tehniyat Baig, MD
05:30 PM - 06:30 PM	Abstract	13-009 - Scrub Typhus: Case of a Rare Etiology Behind Intracerebral Hemorrhage Ahmad Ozair
05:30 PM - 06:30 PM	Abstract	13-010 - Bartonella Henselae Infection Manifesting with Multiple Cranial Neuropathies Tiffany Lei
05:30 PM - 06:30 PM	Abstract	13-011 - Bilateral Sensorineural Hearing Loss: A Unique Sequelae of Murine Typhus Aseptic Meningitis Justin Samorajski, MD
05:30 PM - 06:30 PM	Abstract	13-012 - Native-Valve Legionella Endocarditis with Devastating Neurological Complications Meryim Poursheykhi, MD
05:30 PM - 06:30 PM	Abstract	13-013 - A Challenging Case of Progressive Pachymeningitis Elizabeth Pedowitz, MD
05:30 PM - 06:30 PM	Abstract	13-014 - Encephalopathy with restricted diffusion in the splenium of corpus callosum in a case of Legionella Pneumophilia infection Magdalena Stepien, MD
05:30 PM - 06:30 PM	Abstract	13-015 - Streptococcus intermedius: an unusual culprit of simultaneous cerebral and cord intramedullary abscesses Muhammad H. Jaffer, MD
05:30 PM - 06:30 PM	Abstract	13-016 - A Rare Case Of Guillain-Barre Syndrome Associated with Nontuberculous Mycobacterium Infection Subhendu Rath, MBBS
05:30 PM - 06:30 PM	Abstract	13-017 - Bihemispheric Cortical Infarcts in a Patient with E.Coli Meningitis Bhanu Gogia, MBBS
05:30 PM - 06:30 PM	Abstract	5-001 - A Series of Unfortunate Strokes Steve Bibu, MD
05:30 PM - 06:30 PM	Abstract	5-002 - Acute Hyperextension “Surfer’s” Myelopathy in a Gymnast: Bending over Backwards for Diagnosis Rebecca J. Levy, MD
05:30 PM - 06:30 PM	Abstract	5-003 - The use of gadolinium based contrast agents in pediatric brain MRIs: The indications and yield. Anila Kanna, MD
05:30 PM - 06:30 PM	Abstract	5-004 - Effect of Nutrition Support Therapy on Outcomes in Children with Moderate to Severe Traumatic Brain Injury Chelsea G. McElroy
05:30 PM - 06:30 PM	Abstract	5-005 - Idiopathic Intracranial Hypertension in children: Are we missing something? Lokesh Saini, DM
05:30 PM - 06:30 PM	Abstract	5-006 - A Rare Case of Spontaneous Arachnoid Cyst Rupture Presenting as Right Hemiplegia and Expressive Aphasia in a Pediatric Patient Natalie A. Majors, MD
05:30 PM - 06:30 PM	Abstract	5-007 - Age-at-onset and Time-to-event of Core Features in CLN3 (Batten) Disease Margaux C. Masten, Undergraduate
05:30 PM - 06:30 PM	Abstract	5-008 - Quantitative Gait Analysis in CLN3 Disease Grace A. Zimmerman, MPH
05:30 PM - 06:30 PM	Abstract	5-009 - A Neurological Assessment Scale For Infantile Neuroaxonal Dystrophy
05:30 PM - 06:30 PM	Abstract	5-010 - Atypical phenotypes caused by the ATP1A3 variant p.P775L Daniel Calame, MD, PhD
05:30 PM - 06:30 PM	Abstract	5-011 - Evidence of pharmacodynamic tolerance during repeated daily gaboxadol exposure in individuals with Angelman syndrome Tom Parry
05:30 PM - 06:30 PM	Abstract	5-012 - Physiologically based pharmacokinetic modeling (PBPK) for gaboxadol exposure in children with Angelman syndrome
05:30 PM - 06:30 PM	Abstract	5-013 - Caregiver insight on the core domains in Angelman syndrome Anna Lee
05:30 PM - 06:30 PM	Abstract	5-014 - Quality of Life in Adolescent and Adult Individuals with Angelman Syndrome: Baseline Results from the Phase 2 STARS Study
05:30 PM - 06:30 PM	Abstract	5-015 - The pivotal Phase 3 NEPTUNE trial investigating gaboxadol in Angelman syndrome: Study design

Faculty Disclosures
Ilana B. Katz Sand, MD	The institution of Dr. Katz Sand has received research support from National Multiple Sclerosis Society. The institution of Dr. Katz Sand has received research support from Hirschl Foundation. The institution of Dr. Katz Sand has received research support from National Institutes of Health. Dr. Katz Sand has received personal compensation in the range of $500-$4,999 for serving as a Conference presenter with �鶹��ýӳ��.
Ruple S. Laughlin, MD, F�鶹��ýӳ��	Dr. Laughlin has nothing to disclose.
Richard J. Barohn, MD, F�鶹��ýӳ��	Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Christian Brandt, MD	Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW. Dr. Brandt has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Desitin. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvelle. Dr. Brandt has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Brandt has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zogenix. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Arvelle. The institution of Dr. Brandt has received research support from Rubin-Stiftung. Dr. Brandt has received publishing royalties from a publication relating to health care.
Roy L. Freeman, MD	Dr. Freeman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cutaneous Diagnostic Life Sciences. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck. Dr. Freeman has received research support from Regeneron.
Anne Louise Oaklander, MD, PhD, F�鶹��ýӳ��	The institution of Dr. Oaklander has received research support from National Institutes of Health.
Michael J. Polydefkis, MD, F�鶹��ýӳ��	Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceutical . Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer.
Yahia M. Lodi, MD, F�鶹��ýӳ��	Dr. Lodi has nothing to disclose.
Leonard van den Berg, MD	The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ferrrer. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Projenx. Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Van den Berg has received research support from Netherlands ALS Foundation.
Shawna M. Cutting, MD, F�鶹��ýӳ��	The institution of Dr. Cutting has received research support from Genentech.
Jee H. Jeong, MD	Dr. Jeong has nothing to disclose.
Osvaldo J. Nascimento, MD, PhD, F�鶹��ýӳ��	Dr. Nascimento has nothing to disclose.
Giacomo Lus	Giacomo Lus has nothing to disclose.
Luca Massacesi	The institution of Luca Massacesi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck-Serono. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson and Johnson. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. The institution of Luca Massacesi has received research support from Tuscan Region Government. The institution of Luca Massacesi has received research support from Sanofi. The institution of Luca Massacesi has received research support from Roche. Luca Massacesi has received research support from Merck-Serono.
	No disclosure on file
Erin Longbrake, MD, PhD, F�鶹��ýӳ��	Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Longbrake has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Longbrake has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Longbrake has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ACTRIMS. Dr. Longbrake has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Longbrake has received research support from Genentech. The institution of Dr. Longbrake has received research support from NINDS K23. The institution of Dr. Longbrake has received research support from Robert Patterson Leet Trust. The institution of Dr. Longbrake has received research support from Biogen. The institution of Dr. Longbrake has received research support from National MS Society. The institution of Dr. Longbrake has received research support from Department of Defense. Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with Department of Defense (CDMRP). Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Programmatic Review with Department of Defense (CDMRP). Dr. Longbrake has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with National Institute of Health .
Roland M. Martin, MD	No disclosure on file
Massimo Filippi, MD, F�鶹��ýӳ��	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
P. James B. Dyck, MD, F�鶹��ýӳ��	Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Oivind Torkildsen	No disclosure on file
Rajanandini Muralidharan, MD, F�鶹��ýӳ��	Dr. Muralidharan has nothing to disclose.
Roberta Messina, MD, PhD	Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Organon. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly.
Pedro Gonzalez-Alegre, MD	Dr. Gonzalez-Alegre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Gonzalez-Alegre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Therapeutics. Dr. Gonzalez-Alegre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuExcell. The institution of Dr. Gonzalez-Alegre has received research support from NIH/NINDS. Dr. Gonzalez-Alegre has received intellectual property interests from a discovery or technology relating to health care.
A. Gordon Smith, MD, F�鶹��ýӳ��	Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for US Department of Justice. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Lexicon. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Smith has received research support from NIH (NINDS, NIDDK). Dr. Smith has received publishing royalties from a publication relating to health care. Dr. Smith has received personal compensation in the range of $0-$499 for serving as a Study Section with NIH.
Shadi Yaghi, MD	Dr. Yaghi has nothing to disclose.
Maria Trojano	Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi_Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Jonathan W. Mink, MD, PhD, F�鶹��ýӳ��	The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for �鶹��ýӳ��. The institution of Dr. Mink has received research support from Neurogene. The institution of Dr. Mink has received research support from NIH. Dr. Mink has received publishing royalties from a publication relating to health care. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Member, Study Section with NINDS.
Heather Adams	The institution of Heather Adams has received research support from Current: NIH; Past: Abeona; Batten Research Alliance; American University Centers on Disabilities. An immediate family member of Heather Adams has received publishing royalties from a publication relating to health care. Heather Adams has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Critical Path Institute.
Alessandro Meani	Alessandro Meani has nothing to disclose.
Christopher D. Stephen, MB ChB, FRCP, MSc, SM	The institution of Dr. Stephen has received research support from Sanofi. Dr. Stephen has received research support from National Institutes of Health.
Eoin P. Flanagan, MBBCh, F�鶹��ýӳ��	The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to �鶹��ýӳ�� interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to �鶹��ýӳ�� interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to �鶹��ýӳ�� interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to �鶹��ýӳ�� interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to �鶹��ýӳ�� interests or activities.
Peter J. Dyck, MD, F�鶹��ýӳ��	Dr. Dyck has nothing to disclose.
Gabriel R. De Freitas, MD, PhD	Dr. De Freitas has nothing to disclose.
Paulus S. Rommer	Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for celgene. The institution of Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for merck. Dr. Rommer has received personal compensation in the range of $0-$499 for serving as a Consultant for sanofi. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sandoz. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for almirall. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Dr. Rommer has received research support from merck. The institution of Dr. Rommer has received research support from roche. The institution of Dr. Rommer has received research support from amicus. The institution of Dr. Rommer has received research support from biogen.
Hyunjin Kim, MD	Dr. Kim has nothing to disclose.
Michelle Fullard, MD	Dr. Fullard has received research support from Davis Phinney Foundation. Dr. Fullard has received research support from Michael J. Fox Foundation. The institution of Dr. Fullard has received research support from NIH BIRCWH K12. Dr. Fullard has received research support from Lorna G. Moore Faculty Launch Fund.
Paulus Sugianto, MD, F�鶹��ýӳ��	No disclosure on file
Gabriel Bsteh, MD	Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi.
Jennifer W. McVige, MD, F�鶹��ýӳ��	Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. McVige has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. The institution of Dr. McVige has received research support from Amgen. The institution of Dr. McVige has received research support from Eli Lily. The institution of Dr. McVige has received research support from Biohaven/Pfizer. The institution of Dr. McVige has received research support from Lundbeck. The institution of Dr. McVige has received research support from Dent Family Foundation. The institution of Dr. McVige has received research support from Abbvie. The institution of Dr. McVige has received research support from Teva. The institution of Dr. McVige has received research support from Theranica. Dr. McVige has a non-compensated relationship as a Neurology Board with UCNS that is relevant to �鶹��ýӳ�� interests or activities. Dr. McVige has a non-compensated relationship as a Board Exam Board Member with ABPN that is relevant to �鶹��ýӳ�� interests or activities.
Jayawant N. Mandrekar, PhD	Dr. Mandrekar has nothing to disclose.
Anna Schubart	No disclosure on file
Andrea Boon, MD	Dr. Boon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HPE cosmetics .
Ahmet Hoke, MD, PhD, F�鶹��ýӳ��	Dr. Hoke has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Disarm. Dr. Hoke has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hoke has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Clinical and Translational Neurology. Dr. Hoke has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Burke and Thomas. Dr. Hoke has received stock or an ownership interest from Axoprotego Therapeutics. The institution of Dr. Hoke has received research support from NIH. The institution of Dr. Hoke has received research support from DOD. The institution of Dr. Hoke has received research support from Dr. Miriam and Sheldon G. Adelson Medical Research Foundation. The institution of Dr. Hoke has received research support from Foundation for Peripheral Neuropathy. Dr. Hoke has received intellectual property interests from a discovery or technology relating to health care.
Daniel Calame, MD, PhD	Dr. Calame has nothing to disclose.
Bruno Colombo	Bruno Colombo has nothing to disclose.
Amer Malik, MD	Dr. Malik has nothing to disclose.
Lawrence Korngut, MD	Dr. Korngut has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Korngut has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Korngut has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
David P. Lerner, MD	Dr. Lerner has received publishing royalties from a publication relating to health care.
Gregory M. Blume, MD	No disclosure on file
Frederick J. Marshall, MD	The institution of Dr. Marshall has received research support from CHDI. The institution of Dr. Marshall has received research support from Huntington Study Group.
Alessandra Lugaresi, MD	Dr. Lugaresi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Lugaresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis Pharma. Dr. Lugaresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan. Dr. Lugaresi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Sqibb. Dr. Lugaresi has a non-compensated relationship as a Speaker at meetings, participant in trials with Fondazione Italiana Sclerosi Multipla that is relevant to �鶹��ýӳ�� interests or activities.
An Hong Do, MD	Dr. Do has nothing to disclose.
Caroline B. Braune, MD	Dr. Braune has nothing to disclose.
Ali Mahta, MD	Dr. Mahta has received research support from Brown University Health.
Sean J. Udow, MD	No disclosure on file
Mario F. Mendez, MD, PhD, F�鶹��ýӳ��	Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical �鶹��ýӳ�� Speakers' Bureau. Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Mendez has received research support from NIH. Dr. Mendez has received publishing royalties from a publication relating to health care.
Mia T. Minen, MD, F�鶹��ýӳ��	The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .
Tigran Kesayan, MD	Dr. Kesayan has nothing to disclose.
Allan D. Wu, MD, F�鶹��ýӳ��	Dr. Wu has a non-compensated relationship as a Neuroscience Steering Board with Epic that is relevant to �鶹��ýӳ�� interests or activities. Dr. Wu has a non-compensated relationship as a Subject Matter Expert Panel with Michael J Fox Foundation that is relevant to �鶹��ýӳ�� interests or activities. Dr. Wu has a non-compensated relationship as a Advisory Committee with Parkinson Foundation that is relevant to �鶹��ýӳ�� interests or activities. Dr. Wu has a non-compensated relationship as a Advisory Board with Brain and Life that is relevant to �鶹��ýӳ�� interests or activities. An immediate family member of Dr. Wu has a non-compensated relationship as a Board Member with Illinois State Neurologic Society that is relevant to �鶹��ýӳ�� interests or activities.
James W. Russell, MD, MS, FRPC, F�鶹��ýӳ��	The institution of Dr. Russell has received research support from NIH. Dr. Russell has received publishing royalties from a publication relating to health care.
Francis J. DiMario, Jr., MD	No disclosure on file
Sarah C. Lidstone, MD, PhD	Dr. Lidstone has received publishing royalties from a publication relating to health care.
Alexandre Y. Poppe, MD	The institution of Dr. Poppe has received research support from Stryker. The institution of Dr. Poppe has received research support from Servier.
Helio Afonso G. Teive, MD, PhD, F�鶹��ýӳ��	Dr. Teive has nothing to disclose.
Massimiliano Mirabella, MD	Dr. Mirabella has nothing to disclose.
Sanjay Kalra, MD	The institution of Dr. Kalra has received research support from Brain Canada Foundation. The institution of Dr. Kalra has received research support from Biogen.
Richard F. Lewis, MD	No disclosure on file
Henrik Zetterberg	Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, Roche, and WebMD. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley and Elsevier. Henrik Zetterberg has stock in Brain Biomarker Solutions.
Eun-Jae Lee, MD, PhD	The institution of Prof. Lee has received research support from Republic of Korea .
Roger E. Kelley, Jr., MD, F�鶹��ýӳ��	Dr. Kelley has nothing to disclose.
Jason S. Hawley, MD	Dr. Hawley has nothing to disclose.
Niall Tubridy, MD	Dr. Tubridy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis .
Nutan Sharma, MD, PhD, F�鶹��ýӳ��	Dr. Sharma has nothing to disclose.
Lorne H. Zinman, MD	Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, MTP, AB Science, Cytokinetics, Amylyx. Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx.
Sean Connolly, MD, MRCPI	Dr. Connolly has received publishing royalties from a publication relating to health care.
Maria Pia Sormani	Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol meyer. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Maria Pia Sormani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Vasu Saini, MD	Dr. Saini has nothing to disclose.
Helle Hvilsted Nielsen, MD, PhD	No disclosure on file
Pritikanta Paul, MD	The institution of Dr. Paul has received research support from ZS Associates.
A. M. Barrett, MD, F�鶹��ýӳ��	The institution of Dr. Barrett has received research support from Veterans Health Association. The institution of Dr. Barrett has received research support from National Institutes of Health. The institution of Dr. Barrett has received research support from Mabel H Flory Trust. Dr. Barrett has received personal compensation in the range of $0-$499 for serving as a author, chapter with WebMD. Dr. Barrett has received personal compensation in the range of $10,000-$49,999 for serving as a scientific advisor with Winifred Masterson Burke Foundation.
Michael Sweeney, MD	Dr. Sweeney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Sweeney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Laurie J. Ozelius, PhD	The institution of Dr. Ozelius has received research support from NIH. Dr. Ozelius has received intellectual property interests from a discovery or technology relating to health care.
Ihtsham Haq, MD, F�鶹��ýӳ��	The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation.
Michael Hoffmann, MD, FCP, FAHA, F�鶹��ýӳ��	No disclosure on file
Hacer Durmus, MD	Dr. Durmus has nothing to disclose.
Bradford B. Thompson, MD	Dr. Thompson has nothing to disclose.
Muhammad H. Jaffer, MD	Dr. Jaffer has nothing to disclose.
Fatma Yesim Parman, MD	Dr. Parman has nothing to disclose.
Arshdeep Singh, Jr., MBBS	No disclosure on file
Anita M. Fletcher, MD	Dr. Fletcher has nothing to disclose.
Lokesh Saini, DM	Dr. Saini has nothing to disclose.
Nicola De Stefano, MD	Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Healthcare KGaA. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono S.p.A. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche S.p.A.. The institution of Dr. De Stefano has received research support from Italian MS Society. The institution of Dr. De Stefano has received research support from Merck Healthcare KGaA.
Sami L. Khella, MD, F�鶹��ýӳ��	Dr. Khella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos.
Claire Riley, MD, F�鶹��ýӳ��	Dr. Riley has received personal compensation for serving as an employee of AstraZeneca. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta Bio. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Christopher R. Newey, DO	Dr. Newey has nothing to disclose.
Sylvia Klineova, MD	Dr. Klineova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Klineova has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Klineova has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Klineova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Ali R. Shoraka, MD	No disclosure on file
Avalon O'Connor	No disclosure on file
Eugene Schneider, MD	Dr. Schneider has received personal compensation for serving as an employee of ionis pharmaceuticals.
Michelle Fabian, MD, F�鶹��ýӳ��	Dr. Fabian has nothing to disclose.
Klaus Schmierer, MD, PhD	Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AXDEV. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MedScape. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroDiem. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Academy. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for F. Hoffmann-La Roche AG. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
Nancy M. Nealon, MD	Dr. Nealon has nothing to disclose.
Sat Dev Batish, PhD, F�鶹��ýӳ��	Dr. Batish has received stock or an ownership interest from Quest Diagnostics.
Constantine Farmakidis, MD, F�鶹��ýӳ��	Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J&J. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Muscular Dystrophy Association.
Suzanne J. Hodgkinson, MD, MBBS, PhD, FRACP	The institution of Dr. Hodgkinson has received research support from MERCK. The institution of Dr. Hodgkinson has received research support from Atara. The institution of Dr. Hodgkinson has received research support from Biogen . The institution of Dr. Hodgkinson has received research support from Genzyme. The institution of Dr. Hodgkinson has received research support from ROCHE. The institution of Dr. Hodgkinson has received research support from Novartis.
Sam H. Horng, MD, PhD	The institution of Dr. Horng has received research support from National Institutes of Health . The institution of Dr. Horng has received research support from Jayne and Harvey Beker Foundation .
Tobias Derfuss	An immediate family member of Tobias Derfuss has received personal compensation for serving as an employee of Roche. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. The institution of Tobias Derfuss has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GeNeuro. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuraxpharm. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson&Johnson. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Sharp Dome. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedDay. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Merck. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Roche. An immediate family member of Tobias Derfuss has stock in Novartis. An immediate family member of Tobias Derfuss has stock in Roche. The institution of Tobias Derfuss has received research support from Roche. The institution of Tobias Derfuss has received research support from Biogen. The institution of Tobias Derfuss has received research support from Alexion.
Elizabeth Pedowitz, MD	No disclosure on file
Chun Chu, MD, PhD	Dr. Chu has nothing to disclose.
Mariam Hull, MD	Dr. Hull has received publishing royalties from a publication relating to health care.
Nicholas Viney	Nicholas Viney has received personal compensation for serving as an employee of Ionis Pharmaceuticals Inc.. Nicholas Viney has stock in Ionis Pharmaceuticals. Nicholas Viney has received intellectual property interests from a discovery or technology relating to health care.
Bill Aschenbach	No disclosure on file
Birgit Keller	Birgit Keller has received personal compensation for serving as an employee of Merck Healthcare KGaA.
Vinay Puri, MD	Dr. Puri has received personal compensation for serving as an employee of neurelis. Dr. Puri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Puri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Puri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai.
Ashis H. Tayal, MD	Dr. Tayal has nothing to disclose.
Finn Sellebjerg, MD	Dr. Sellebjerg has received personal compensation for serving as an employee of Danish Multiple Sclerosis Society. Dr. Sellebjerg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Gangsted Foundation. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Warwara Larsen Foundation. The institution of Dr. Sellebjerg has received research support from Biogen. The institution of Dr. Sellebjerg has received research support from Merck. The institution of Dr. Sellebjerg has received research support from Novartis. The institution of Dr. Sellebjerg has received research support from Sanofi Genzyme. Dr. Sellebjerg has received publishing royalties from a publication relating to health care.
Anat Achiron, MD, PhD, F�鶹��ýӳ��	Dr. Achiron has nothing to disclose.
Zarife F. Sahenk, MD, PhD, F�鶹��ýӳ��	Dr. Sahenk has nothing to disclose.
Miguel Chuquilin Arista, MD, F�鶹��ýӳ��	Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item writer with �鶹��ýӳ��. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item Writer with �鶹��ýӳ��. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item Writer with �鶹��ýӳ��. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item reviewer with National Board of Medical Examiners. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Southeast regional advisory board with Argenx. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Focus group with Alexion. Dr. Chuquilin Arista has received personal compensation in the range of $0-$499 for serving as a Speaker with Periodic Paralysis Association.
Zachary Macchi, MD	The institution of Dr. Macchi has received research support from NIH/NIA.
Ursula Boschert Shafaatian	Ursula Boschert has nothing to disclose.
Farida Abid, MD	No disclosure on file
Cecilia Monteiro, MD, PhD	No disclosure on file
Eric Segal, MD	Dr. Segal has received personal compensation for serving as an employee of Lundbeck. Dr. Segal has received personal compensation for serving as an employee of Eisai. Dr. Segal has received personal compensation for serving as an employee of Neurelis. Dr. Segal has received personal compensation for serving as an employee of Zogenix. Dr. Segal has received personal compensation for serving as an employee of Aquestive. Dr. Segal has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. Segal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Segal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwhich Bioscience. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Greenwhich Bioscience. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis.
Bhanu Gogia, MBBS	Dr. Gogia has nothing to disclose.
Antonio Bertolotto, MD, F�鶹��ýӳ��	Dr. Bertolotto has nothing to disclose.
Richard S. Geary	No disclosure on file
Claudiu I. Diaconu, MD	No disclosure on file
Katrina Peariso, MD, PhD	No disclosure on file
Prashant Natteru, MBBS	Dr. Natteru has nothing to disclose.
Alexandre Prat, MD	The institution of Dr. Prat has received research support from CIHR and MSSC.
Danny Bega, MD	Dr. Bega has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus Pharmaceuticals. Dr. Bega has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SOM. Dr. Bega has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine Biosciences.
Nicholas Blondin, MD	Dr. Blondin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure, Inc.. Dr. Blondin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure, Inc..
Rebecca G. Straus Farber, MD	Dr. Straus Farber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics.
Ivo Bach, MD	Dr. Bach has nothing to disclose.
Wendy S. Vargas, MD	Dr. Vargas has received personal compensation for serving as an employee of Sanofi.
Peng Soon Ng, MBBS	No disclosure on file
Duaa Jabari, MD	Dr. Jabari has nothing to disclose.
Andrew Chan	The institution of Andrew Chan has received research support from UCB. The institution of Andrew Chan has received research support from Biogen. The institution of Andrew Chan has received research support from Sanofi Genzyme.
Pratit D. Patel, MD	Dr. Patel has nothing to disclose.
Hartmut Uschmann, MD	Dr. Uschmann has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Samson & Powers, PLLC.
Christopher Langston, MD	No disclosure on file
Agustin Oterino Duran, MD	No disclosure on file
Nathan P. Staff, MD, PhD, F�鶹��ýӳ��	Dr. Staff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stem Cell Research & Therapy. Dr. Staff has received research support from National Institutes of Health.
Mazen M. Dimachkie, MD, F�鶹��ýӳ��	Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for �鶹��ýӳ�� (�鶹��ýӳ��). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (�鶹��ýӳ��EM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Samantha K. Holden, MD, MS, F�鶹��ýӳ��	The institution of Dr. Holden has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics.
Fred D. Lublin, MD, F�鶹��ýӳ��	Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Patrick Vermersch	Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Juliann M. Paolicchi, MD	No disclosure on file
Heinz Wiendl, MD, F�鶹��ýӳ��	Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Aparna M. Prabhu, MD	Dr. Prabhu has nothing to disclose.
Naresh Mullaguri, MD	Dr. Mullaguri has nothing to disclose.
Arooj Kohli, MD	Dr. Kohli has nothing to disclose.
Casey J. Judge, DO	Dr. Judge has nothing to disclose.
Sonia Partap, MD, F�鶹��ýӳ��	The institution of Dr. Partap has received research support from NIH.
Frederik Barkhof, MD, PhD	Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Hussam A. Yacoub, DO	Dr. Yacoub has nothing to disclose.
Robert Staudinger, MD, F�鶹��ýӳ��	Dr. Staudinger has nothing to disclose.
Enrique A. Feoli, MD	Dr. Feoli has nothing to disclose.
Priyank Khandelwal, MD	Dr. Khandelwal has nothing to disclose.
Amelia K. Adcock, MD	The institution of an immediate family member of Dr. Adcock has received research support from NIH.
Carlos Henrique F. Camargo, MD, PhD, MSc, F�鶹��ýӳ��	Dr. Camargo has nothing to disclose.
Lobat Hashemi	No disclosure on file
Katherine Moretz, MD	No disclosure on file
Philip De Jager, MD, PhD	Dr. De Jager has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Puretech. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. The institution of Dr. De Jager has received research support from roche. The institution of Dr. De Jager has received research support from puretech.
Syed Rizvi, MD	Dr. Rizvi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono Roche Bristol Myers . Dr. Rizvi has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Na.
Robert Fishman, MD	Dr. Fishman has nothing to disclose.
Marcus Vinicius R. Pinto, MD	Dr. Pinto has nothing to disclose.
Charlie Conway	Charlie Conway has received personal compensation for serving as an employee of Biohaven Pharmaceuticals Inc. Charlie Conway has received stock or an ownership interest from Biohaven Pharmaceuticals.
Gene Dubowchik	Gene Dubowchik has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gene Dubowchik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Morrison Foerster.
Vladimir Coric	Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
Brian Sansoucy	No disclosure on file
Anusha Yeshokumar, MD	Dr. Yeshokumar has nothing to disclose.
Barbara O'Brien, MD	Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PlusTherapeutics.
Bogdan I. Patedakis Litvinov, MD	No disclosure on file
Li-Jung Tai, MD, PhD	Li-Jung Tai has received personal compensation for serving as an employee of Avidity Biosciences. Li-Jung Tai has received stock or an ownership interest from Avidity.
Jared Cook	No disclosure on file
Matthew Schrag, MD	No disclosure on file
Brian Mac Grory, MB BCh BAO	An immediate family member of Dr. Mac Grory has received personal compensation for serving as an employee of Sanofi. Dr. Mac Grory has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Mac Grory has received research support from National Institutes of Health. The institution of Dr. Mac Grory has received research support from American Heart Association.
Michael P. Stanley, MD	Dr. Stanley has received personal compensation in the range of $0-$499 for serving as a Consultant for Roon. Dr. Stanley has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Stanley has stock in Roon. Dr. Stanley has received personal compensation in the range of $0-$499 for serving as a writer at large with WBUR/Cognoscenti . Dr. Stanley has received personal compensation in the range of $0-$499 for serving as a Poet with Writing the Land. Dr. Stanley has received personal compensation in the range of $0-$499 for serving as a writer at large with Psyche. Dr. Stanley has received personal compensation in the range of $0-$499 for serving as a Writer at large with Wall Street Journal.
Tracy E Madsen	No disclosure on file
Konrad Rejdak, PhD	Dr. Rejdak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck, Biogen, Bayer, Sanofi, Teva, Roche, Takeda. Dr. Rejdak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Biogen, Bayer, Sanofi, Teva, Roche, Takeda.
Appaji Rayi, MD, F�鶹��ýӳ��	Dr. Rayi has nothing to disclose.
Kathleen J. Sweadner, PhD	The institution of Dr. Sweadner has received research support from Hope for Annabel, AHC Foundation, and CureAHC. The institution of Dr. Sweadner has received research support from the Chan-Zuckerberg Initiative.
Golnoush Akhlaghipour, MD	Dr. Akhlaghipour has nothing to disclose.
Hamza I. Maqsood, MD	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Maximiliano A. Hawkes, MD	Dr. Hawkes has or had stock in Navinetics-AI.
Naveen Sankhyan, MD, MBBS, DM	The institution of Dr. Sankhyan has received research support from PTC Therapeutics for a Multicentric RCT. Dr. Sankhyan has received research support from Institute Grant, PGIMER, (Goverment Entity).
Jitendra Sahu, MD	Jitendra Sahu has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Indian Journal of Pediatrics. The institution of Jitendra Sahu has received research support from Indian Council of Medical Research.
Nehal Jain	No disclosure on file
Harpreet S. Mann, DM	No disclosure on file
Amy Vierhile, NP, DNP	Ms. Vierhile has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Biosciences.
Hoda Seens, MD	No disclosure on file
Mayank Verma, MD, PhD	No disclosure on file
Bvchaitanya Reddy, Sr., MD	Dr. Reddy has nothing to disclose.
Ihedinachi Ndukwe, MD	Dr. Ndukwe has nothing to disclose.
Mark Midei, MD	Dr. Midei has received personal compensation for serving as an employee of Retrotope. Dr. Midei has received stock or an ownership interest from Retrotope.
Meryim Poursheykhi, MD	Dr. Poursheykhi has nothing to disclose.
Basil Sharrack, MD, PhD, F�鶹��ýӳ��	Dr. Sharrack has nothing to disclose.
Carolina Barnett Tapia, MD	Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD pharma. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. The institution of Dr. Barnett Tapia has received research support from Department of defense. The institution of Dr. Barnett Tapia has received research support from Muscular dystrophy canada. The institution of Dr. Barnett Tapia has received research support from MgNet. The institution of Dr. Barnett Tapia has received research support from NIH. The institution of Dr. Barnett Tapia has received research support from Cartesian. The institution of Dr. Barnett Tapia has received research support from Alexion. Dr. Barnett Tapia has received intellectual property interests from a discovery or technology relating to health care.
Amanda B. Weber, DO	Dr. Weber has nothing to disclose.
Franklyn Rocha Cabrero, MD	Dr. Rocha Cabrero has nothing to disclose.
Timothy E. Lotze, MD, F�鶹��ýӳ��	Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.
Angela L. Genge, MD	Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE. Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for eikonizo. Dr. Genge has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for rapa.
Young-Min Lim, MD	Dr. Lim has nothing to disclose.
Damiano Paolicelli	Damiano Paolicelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Damiano Paolicelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Kwang-Kuk Kim, MD	No disclosure on file
Zia Choudhry	No disclosure on file
Robert Croop, MD	Dr. Croop has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Dr. Croop has received personal compensation for serving as an employee of Pfizer Inc.. Dr. Croop has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Collima LLC. Dr. Croop has stock in Biohaven Pharmaceutical Holding Co Ltd. Dr. Croop has stock in Biohaven Ltd.. Dr. Croop has stock in Actio Biosciences, Inc. . Dr. Croop has received research support from Pfizer Inc. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care.
Marie Coste	No disclosure on file
Mark Ozog, PhD	No disclosure on file
Vivekananda Datta	Vivekananda Datta has received personal compensation for serving as an employee of Quest Diagnostics.
John Peters, MD	Dr. Peters has nothing to disclose.
Ilena George, MD	The institution of Dr. George has received research support from Biogen.
Bradley Shane, MD	Dr. Shane has nothing to disclose.
Kaleb H. Yohay, MD	Dr. Yohay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Yohay has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Yohay has received publishing royalties from a publication relating to health care.
Spurthi Surpur, MD	Dr. Surpur has nothing to disclose.
Allison Brashear, MD, MBA, F�鶹��ýӳ��	Dr. Brashear has received personal compensation for serving as an employee of McKnight Brain Res Found. Dr. Brashear has received personal compensation for serving as an employee of American Board of Psychiatry and Neurology. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation i. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Care Directions- start up . Dr. Brashear has stock in Caredirections . The institution of Dr. Brashear has received research support from NINDS. Dr. Brashear has received publishing royalties from a publication relating to health care. Dr. Brashear has received personal compensation in the range of $500-$4,999 for serving as a Special government employee and study section reviewer with NIH. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as a Adminstrative board -travel reimbursement with AAMC.
Alan R. Hirsch, MD, FACP	Dr. Hirsch has nothing to disclose.
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Jinny O. Tavee, MD	Dr. Tavee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Tavee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Tavee has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. The institution of Dr. Tavee has received research support from Woolsey. The institution of Dr. Tavee has received research support from Milken Foundation. The institution of Dr. Tavee has received research support from CSL Behring. Dr. Tavee has received personal compensation in the range of $0-$499 for serving as a Article author with Medlink.
E. M. Hoffman, DO, PhD	Dr. Hoffman has nothing to disclose.
Christopher T. Whitlow, MD	Dr. Whitlow has nothing to disclose.
Stephen A. Johnson, MD	The institution of Dr. Johnson has received research support from ALS Association.
Jeenendra P. Singhvi, MD, F�鶹��ýӳ��	Dr. Singhvi has nothing to disclose.
Irine Siraj, MD	Dr. Siraj has nothing to disclose.
Erika F. Augustine, MD, F�鶹��ýӳ��	The institution of Dr. Augustine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Latus Bio. Dr. Augustine has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Board of Psychiatry and Neurology. Dr. Augustine has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Augustine has received research support from NIH. The institution of Dr. Augustine has received research support from Beyond Batten Disease Foundation. Dr. Augustine has received publishing royalties from a publication relating to health care. Dr. Augustine has a non-compensated relationship as a Member, Board of Directors with American Brain Foundation that is relevant to �鶹��ýӳ�� interests or activities. Dr. Augustine has a non-compensated relationship as a Scientific Advisor with ARIA that is relevant to �鶹��ýӳ�� interests or activities.
Beverly Snively	The institution of Beverly Snively has received research support from National Institutes of Health. The institution of Beverly Snively has received research support from Duke Endowment. The institution of Beverly Snively has received research support from Department of Defense. The institution of Beverly Snively has received research support from PCORI.
Marc Bigaud	Marc Bigaud has received personal compensation for serving as an employee of Novartis Pharma.
Shyam S. Rao, MD	No disclosure on file
Adrian Budhram, MD	Dr. Budhram has nothing to disclose.
Oleg Y. Yerstein, MD	Dr. Yerstein has nothing to disclose.
Yun Fang	No disclosure on file
Kendall A. Hodges, NP	No disclosure on file
Shahar Shelly, MD	Dr. Shelly has or had stock in Remepy.
Brian S. LaGrant, MD	No disclosure on file
Sara J. Doyle, MD	No disclosure on file
Natalie A. Majors, MD	No disclosure on file
Jon Stone, PhD, MB, ChB, FRCP	Mr. Stone has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple UK legal firms. The institution of Mr. Stone has received research support from Scottish Government. Mr. Stone has received publishing royalties from a publication relating to health care. Mr. Stone has a non-compensated relationship as a President Elect with FND Society that is relevant to �鶹��ýӳ�� interests or activities.
Paolo Muraro	Paolo Muraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Paolo Muraro has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Pinsent Masons LLP. Paolo Muraro has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Taylor Wessing LLP. Paolo Muraro has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Bugge Valentin. Paolo Muraro has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Lambert Hornby LLP. The institution of Paolo Muraro has received research support from NIHR-EME. The institution of Paolo Muraro has received research support from Benaroya Research Institute.
Rebecca J. Levy, MD	Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. An immediate family member of Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for SRB Hawaii Law LLC. An immediate family member of Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wisner Baum LLP. The institution of Dr. Levy has received research support from CNCDP-K12. The institution of Dr. Levy has received research support from NINDS.
Kaho Onomichi	Kaho Onomichi has nothing to disclose.
Raul Anwar Garcia Santos, MD	Dr. Santos has nothing to disclose.
Elizabeth Poole	No disclosure on file
Chaitanya Medicherla, MD	Dr. Medicherla has nothing to disclose.
Chelsea G. McElroy	No disclosure on file
Kiersten M. Dykstra, PA, OT	No disclosure on file
Dhimant Dani, MD	Dr. Dani has nothing to disclose.
Manoj Malhotra, MD	Dr. Malhotra has received personal compensation for serving as an employee of Eisai.
Gilbert O. Mbeo, MD	No disclosure on file
Shirley Ju, MD	No disclosure on file
Corey A. McGraw, MD	The institution of Dr. McGraw has received research support from Novartis. The institution of Dr. McGraw has received research support from F. Hoffmann - La Roche. The institution of Dr. McGraw has received research support from Genentech. The institution of Dr. McGraw has received research support from Neurona Therapeutics. The institution of Dr. McGraw has received research support from Instituto Grifols, S.A..
Karan S. Dixit, MD	Dr. Dixit has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier.
Laura Cacciaguerra, MD, PhD	Dr. Cacciaguerra has nothing to disclose.
Amit S. Singh, MD	Dr. Singh has nothing to disclose.
Amy Kunchok, MBBS	Dr. Kunchok has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology:Open Access Journal .
Ilya Kister, MD, F�鶹��ýӳ��	Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Sebastian F. Ameriso, MD	Dr. Ameriso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PHRI. Dr. Ameriso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer, Boehringer, Abbott, AstraZeneca.
Linda C. Wendell, MD, F�鶹��ýӳ��	Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. An immediate family member of Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Wendell has stock in Apple. An immediate family member of Dr. Wendell has stock in Apple.
Christoph Stretz, MD, F�鶹��ýӳ��	The institution of Dr. Stretz has received research support from American Heart Association. The institution of Dr. Stretz has received research support from Duke University Medical Center/NIH. The institution of Dr. Stretz has received research support from University of Cincinnati/NINDS. The institution of Dr. Stretz has received research support from Biogen, Inc.. The institution of Dr. Stretz has received research support from Brown Physicians, Inc.. Dr. Stretz has a non-compensated relationship as a Editorial Board Member with Neurology: Clinical Practice that is relevant to �鶹��ýӳ�� interests or activities.
Tamour Khan Tareen, MD, MBBS	Dr. Tareen has nothing to disclose.
Christopher J. Klein, MD, F�鶹��ýӳ��	Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Marta Radaelli	Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme.
David Seder, MD	No disclosure on file
Carlos Ynigo D. Lopez, MD	Dr. Lopez has nothing to disclose.
Rocio Vazquez Do Campo, MD	Dr. Vazquez Do Campo has received personal compensation in the range of $5,000-$9,999 for serving as a Advisor with US Department of Health, vaccine compensation program.
Loredana Storelli	Loredana Storelli has nothing to disclose.
Scott Moody	No disclosure on file
Shehbaz Singh Sidhu	No disclosure on file
Waad Alshammari, MBBS	Dr. Alshammari has nothing to disclose.
Robert Vassallo	Robert Vassallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Robert Vassallo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Rion. Robert Vassallo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Robert Vassallo has stock in Rion LLC. The institution of Robert Vassallo has received research support from NIH. The institution of Robert Vassallo has received research support from DOD. Robert Vassallo has received intellectual property interests from a discovery or technology relating to health care.
Varun Kumar Pala, MD	Dr. Pala has nothing to disclose.
Jasmin Patel, MD	Dr. Patel has nothing to disclose.
Kyutae Kim	No disclosure on file
Robert G. Michaud, Jr.	No disclosure on file
Rajeel Imran, MD	Dr. Imran has nothing to disclose.
Francisco Germiniani	No disclosure on file
Claudia J. Chaves, MD, F�鶹��ýӳ��	No disclosure on file
Tyler A. Gumpel	Tyler Gumpel has nothing to disclose.
John M. Wright, Jr., MD	Dr. Wright has nothing to disclose.
Odai Abdalla, MBBS	Dr. Abdalla has nothing to disclose.
Hans D. Katzberg, MD, F�鶹��ýӳ��	An immediate family member of Dr. Katzberg has received personal compensation for serving as an employee of Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Katzberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX.
Thomas A. Berger, MD	Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
Eduardo R. Pereira, MD	No disclosure on file
Oleg Y. Chernyshev, MD, PhD, F�鶹��ýӳ��	Dr. Chernyshev has nothing to disclose.
M. Tariq Bhatti, MD	Dr. Bhatti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Receptos . Dr. Bhatti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH LHON gene therapy study .
Elio A. Scarpini, MD	No disclosure on file
Nilufer Yalcin, MD	Dr. Yalcin has nothing to disclose.
Michael Doyle, MRCPI	No disclosure on file
Seung Min Kim	Seung Min Kim has received research support from Veterans Health Service Medical Center Research Grant.
Joao Marcos C. Ferreira, Sr., MD	No disclosure on file
Katarina B. Dakay, DO	No disclosure on file
Shyamal C. Bir, MD	Dr. Bir has nothing to disclose.
Tiffany Lei	No disclosure on file
Sho T. Yano, MD, PhD	Dr. Yano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley for the journal "Molecular Genetics and Genomic Medicine".
Ruth Arms, NP, APRN-BC	No disclosure on file
Anila Kanna, MD	No disclosure on file
Olwen Murphy, MD	Dr. Murphy has nothing to disclose.
Biniyam A. Ayele, MBBS	No disclosure on file
Daniel M. Oh, MD	Dr. Oh has nothing to disclose.
Benjamin Jiang, MD	Dr. Jiang has nothing to disclose.
Ameer Hassan, DO	Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare.
Michael Hutchinson, MD	Dr. Hutchinson has nothing to disclose.
Sean O'Riordan, MD	Dr. O'Riordan has nothing to disclose.
Duarte G. Machado, MD, F�鶹��ýӳ��	Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
John J. Volpi, MD	Dr. Volpi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovaSignal. Dr. Volpi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for W.L. Gore. Dr. Volpi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Diamedica. Dr. Volpi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Volpi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Volpi has received intellectual property interests from a discovery or technology relating to health care.
Miriam L. Freimer, MD, F�鶹��ýӳ��	Dr. Freimer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for J and J. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Freimer has received research support from Alnylum. The institution of Dr. Freimer has received research support from UCB. The institution of Dr. Freimer has received research support from NIH. The institution of Dr. Freimer has received research support from Janssen. Dr. Freimer has received research support from Avidity. Dr. Freimer has received research support from Fulcrum. The institution of Dr. Freimer has received research support from Dept of defense. The institution of an immediate family member of Dr. Freimer has received research support from Abcurro. Dr. Freimer has received personal compensation in the range of $10,000-$49,999 for serving as a presentations/teaching with UCB.
Antonio Arauz, MD, PhD	Dr. Arauz has nothing to disclose.
Mered Parnes, MD	Dr. Parnes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. Dr. Parnes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. The institution of Dr. Parnes has received research support from NIH. The institution of Dr. Parnes has received research support from Alexion.
Kiran Thakur, MD, F�鶹��ýӳ��	Dr. Thakur has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio.
Omar Jawdat, MD	Dr. Jawdat has nothing to disclose.
Seth N. Levin, MD	Dr. Levin has received personal compensation for serving as an employee of Biogen. Dr. Levin has received stock or an ownership interest from Biogen.
Jaspreet Johal, MD	Dr. Johal has nothing to disclose.
Mamatha Pasnoor, MD, F�鶹��ýӳ��	Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
James M. Gilchrist, MD, F�鶹��ýӳ��	Dr. Gilchrist has received publishing royalties from a publication relating to health care.
Letizia M. Leocani, MD	Dr. Leocani has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche . Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Med-ex learning.
Zongqi Xia, MD, PhD	The institution of Dr. Xia has received research support from National Institute of Health. The institution of Dr. Xia has received research support from Genentech/Roche.
Faisal A. Ibrahim, MD	Dr. Ibrahim has nothing to disclose.
Rachel Brandstadter, MD	Dr. Brandstadter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Chaitanya Amrutkar, MD	No disclosure on file
Brett Monia, PhD	No disclosure on file
Pravin George, DO	Dr. George has nothing to disclose.
Luis Magalhaes	Luis Magalhaes has received personal compensation for serving as an employee of BIAL-Portela & Cª, S.A..
Maria Luisa R. Prata, MD	No disclosure on file
Xue Y. Chen	No disclosure on file
Jessica White, MD	Dr. White has nothing to disclose.
Bindi A. Nia, DO	Dr. Patel has nothing to disclose.
Vanessa C. Colares Lessa, MD	Dr. Colares Lessa has nothing to disclose.
Maria A. Garcia-Dominguez, MD	Dr. Garcia-Dominguez has received personal compensation for serving as an employee of Genentech.
Augusto Rini, MD	No disclosure on file
Conrad J. Goerz, MD	No disclosure on file
Luis Felipe Haberfeld Maia, MD	No disclosure on file
Nnenna Asidianya	No disclosure on file
Felisitas Farica Sutantoyo	No disclosure on file
Fritz Leutmezer	Fritz Leutmezer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Almirall, Biogen, Celgene, Johnson&Johnson, Novartis, Merck, Roche, Sanofi, Teva-Ratiopharm. Fritz Leutmezer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall, Biogen, Celgene, Johnson&Johnson, Novartis, Merck, Roche, Sanofi, Teva-Ratiopharm. Fritz Leutmezer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Almirall, Biogen, Celgene, Johnson&Johnson, Novartis, Merck, Roche, Sanofi, Teva-Ratiopharm. The institution of Fritz Leutmezer has received research support from Biogen, Merck, Novartis, Roche.
Todd Grinnell, PhD	Todd Grinnell, PhD has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Paul B. Ferguson, MD, F�鶹��ýӳ��	Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Ferguson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan.
Carlos A. Pardo-Villamizar, MD	The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Jennifer A. Vermilion, MD	The institution of Dr. Vermilion has received research support from Centers for Disease Control. The institution of Dr. Vermilion has received research support from Emalex Biosciences. The institution of Dr. Vermilion has received research support from Biomarin. The institution of Dr. Vermilion has received research support from Neurogene, Inc. Dr. Vermilion has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker with Tourette Association of America. Dr. Vermilion has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker with Centers for Disease Control and Prevention and American Academy of Pediatrics.
Agessandro Abrahao, Jr., MD	Dr. Abrahao has nothing to disclose.
Fatemeh Khadjevand, MD, MPH	Dr. Khadjevand has nothing to disclose.
Salman Assad, MD, MBBS	Dr. Assad has nothing to disclose.
Patrick Altmann	The institution of Mr. Altmann has received research support from Quanterix. The institution of Mr. Altmann has received research support from Biogen, Merck, Roche, Sanofi, Teva,. Mr. Altmann has received intellectual property interests from a discovery or technology relating to health care.
Steven Tversky, DO	No disclosure on file
Keith Groshans, MD	Dr. Groshans has nothing to disclose.
Vladana Markovic	No disclosure on file
Tehniyat Baig, MD	Ms. Baig has nothing to disclose.
Amit Rakhit, MD	No disclosure on file
Marco Lyons	No disclosure on file
Sri Raghav S. Sista, MD	Dr. Sista has nothing to disclose.
Muhammad Naeem, MD	No disclosure on file
Jodi Nelson, DO	Dr. Nelson has nothing to disclose.
Gregory N. Beatch, PhD	Dr. Beatch has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc. Dr. Beatch has stock in Xenon Pharmaceuticals Inc. Dr. Beatch has received intellectual property interests from a discovery or technology relating to health care.
Jessica Tom	No disclosure on file
Sanjeev Roy	Sanjeev Roy has received personal compensation for serving as an employee of Merck KgGA.
Saba Shahab	No disclosure on file
Ben Guikema, PhD	No disclosure on file
Justin Samorajski, MD	No disclosure on file
Melissa M. Johnson, MD	Dr. Johnson has nothing to disclose.
Teresa Coelho, MD	Dr. Coelho has nothing to disclose.
Ernesto Aycardi, MD	Dr. Aycardi has received personal compensation for serving as an employee of XENON. Dr. Aycardi has received stock or an ownership interest from XENON.
Deepak J. Soneji, MD	No disclosure on file
Diaa Hamouda	No disclosure on file
Keithan Sivakumar, MD	Dr. Sivakumar has nothing to disclose.
Joshua Battley, MD	Dr. Battley has nothing to disclose.
Alexander J. Senetar, DO	No disclosure on file
Anna Babaie, DO	Dr. Babaie has nothing to disclose.
Saqib A. Chaudhry, MD	Dr. Chaudhry has nothing to disclose.
Sakinah Sabadia, MD	Dr. Sabadia has nothing to disclose.
Julian Acosta, MD	Dr. Acosta has nothing to disclose.
Karen L. Furie, MD	The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Leila Parand, MD	Dr. Parand has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lily. Dr. Parand has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Esai. Dr. Parand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Peer view . Dr. Parand has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Speaker Bureau .
Frederic Heerinckx, PharmD	No disclosure on file
Rashid A. Ahmed, MD	Dr. Ahmed has nothing to disclose.
Hongyan Bi	No disclosure on file
Vittorio Martinelli	Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Sairah Bashir, MD, F�鶹��ýӳ��	Dr. Bashir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic .
Michael Reznik, MD	Dr. Reznik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Morrison Mahoney. The institution of Dr. Reznik has received research support from NIDUS.
Grace A. Zimmerman, MPH	The institution of Ms. Zimmerman has received research support from National Institutes of Health. The institution of Ms. Zimmerman has received research support from Batten Disease Support and Research Association. The institution of Ms. Zimmerman has received research support from Greater Rochester Health Foundation.
Priyanka Madaan	Priyanka Madaan has nothing to disclose.
Arman Cakar	Arman Cakar has nothing to disclose.
Mario E. Ricciardi, Sr., MD	Dr. Ricciardi has nothing to disclose.
Caroline L. Medeiros, Jr., MD	Dr. Medeiros has nothing to disclose.
Justin M. Nolte, MD	Dr. Nolte has nothing to disclose.
Candace B. Borders, MD	Dr. Borders has nothing to disclose.
Sean J. Pittock, MD, F�鶹��ýӳ��	Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Vera Bril, MD	Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Celine Odier, MD	No disclosure on file
Gianna Carla Riccitelli	No disclosure on file
Dileep R. Yavagal, MD, F�鶹��ýӳ��	Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.
Maria Antonietta Mazzola, MD	Dr. Mazzola has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentec.
Sarah F. Wesley, MD, MPH	Dr. Wesley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wesley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wesley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics.
David Cantu, PhD	Dr. Cantu has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Hugo Cuellar-Saenz	No disclosure on file
John Chen	John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. John Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB.
Joachim Burman, MD	No disclosure on file
Alexander Kolevzon	Alexander Kolevzon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ovid Therapeutics. Alexander Kolevzon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Alexander Kolevzon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ovid Therapeutics. Alexander Kolevzon has received stock or an ownership interest from Ovid Therapeutics. The institution of Alexander Kolevzon has received research support from AMO Pharma. Alexander Kolevzon has received publishing royalties from a publication relating to health care.
Ahmad Nehme, MD	No disclosure on file
James Price, DO	No disclosure on file
Paula Barreras, MD	Dr. Barreras has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Barreras has received research support from Foundation for Sarcoidosis Research. The institution of Dr. Barreras has received research support from �鶹��ýӳ��.
John Snowden	John Snowden has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. John Snowden has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. John Snowden has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS.
Susan King	No disclosure on file
Patrick Acuna	Mr. Acuna has nothing to disclose.
Amy W. Laitinen, MD	No disclosure on file
Deena Tajfirouz, MD	Dr. Tajfirouz has nothing to disclose.
Seung-Ah Lee	Miss Lee has nothing to disclose.
Margaux C. Masten, Undergraduate	The institution of Miss Masten has received research support from �鶹��ýӳ��. The institution of Miss Masten has received research support from Neurogene. The institution of Miss Masten has received research support from Amicus. The institution of Miss Masten has received research support from Beyond Batten Disease Foundation. The institution of Miss Masten has received research support from NIH.
Margaret Mondino	No disclosure on file
Arthur Ramalho Monfredinho, MD	Dr. Ramalho Monfredinho has nothing to disclose.
Deepmala Nandanwar, MD	Dr. Nandanwar has nothing to disclose.
Mark S. Freedman, MD, F�鶹��ýӳ��	Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion(Janssen/J&J). Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BiogenIdec. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Inc. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion (Janssen/J&J). Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Healthcare. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BiogenIdec. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRI Bio. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magenta Therapeutics. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Freedman has received research support from Sanofi Genzyme.
Federica Agosta	Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Dominic B. Fee, MD, F�鶹��ýӳ��	An immediate family member of Dr. Fee has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Spine Journal. The institution of Dr. Fee has received research support from ALS Association. The institution of an immediate family member of Dr. Fee has received research support from Veterans Administration.
Michelle Kaku, MD	Dr. Kaku has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Fatcliffe Harten Galamaga LLP.
Jonathan Ciron, MD	Jonathan Ciron, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Jonathan Ciron, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS - Celgene. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Shivkumar Bhadola, MD	Dr. Bhadola has stock in IONIS PHARMACEUTICALS INC. Dr. Bhadola has stock in GINKGO BIOWORKS HOLDINGS INC.
Durjoy Lahiri, MD, DM	Dr. Lahiri has nothing to disclose.
Jacob Didion, MD	No disclosure on file
Biman K. Ray, MD	Dr. Ray has nothing to disclose.
Marie F. Grill, MD	Dr. Grill has nothing to disclose.
Mirela Cerghet, MD, PhD, F�鶹��ýӳ��	Dr. Cerghet has nothing to disclose.
Francesco Patti, MD	Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Almirall. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Almirall, Bayer, Biogen, Bristol Meyers and Squibb Merck, Roche, Sanofi, TEVA. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for University of Catania and AISM/FISM, Fondazione Italiana Sclerosi Multipla. Dr. Patti has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Alexander Vrancken	No disclosure on file
Ziad Hussein	No disclosure on file
Stephan Goedee, MD	No disclosure on file
Sachin Kedar, MD, F�鶹��ýӳ��	Dr. Kedar has nothing to disclose.
Robert T. Wechsler, MD, PhD, F�鶹��ýӳ��	The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Engage. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eliem. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epalex. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Equilibre. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sunovion. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Greenwich/Jazz. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aquestive. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Wechsler has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Epilepsy Studies Consortium. Dr. Wechsler has a non-compensated relationship as a Board President with Epilepsy Foundation of Idaho that is relevant to �鶹��ýӳ�� interests or activities.
Danish Bhatti, MD, F�鶹��ýӳ��	Dr. Bhatti has nothing to disclose.
Cesar Escamilla Ocanas	Mr. Escamilla Ocanas has nothing to disclose.
Melissa Cook, MD	Dr. Cook has nothing to disclose.
Subhendu Rath, MBBS	Dr. Rath has nothing to disclose.
Rahul Damani	Rahul Damani has nothing to disclose.
Daniel A. Crespo, MD	Dr. Crespo has nothing to disclose.
Sungyang Jo, MD	Dr. Jo has nothing to disclose.
Mina Jung, MD	No disclosure on file
Cynthia Arely Juarez Jaramillo	No disclosure on file
Marek Cierny, MD	No disclosure on file
Anna Lee	No disclosure on file
Fernando Dangond, MD, F�鶹��ýӳ��	Dr. Dangond has received personal compensation in the range of $1,000,000+ for serving as a Head, Global Clinical Development (employee for 12 years) with EMD Serono.
Luis Brieva Ruiz, MD	Dr. Brieva Ruiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for All comercial companies interested in Multiple Sclerosis. Dr. Brieva Ruiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Al comercial companies in Multiple Sclerosis. The institution of Dr. Brieva Ruiz has received research support from Carlos III Institut. Madrid. Spain..
Muhammad Affan, MD	Dr. Affan has nothing to disclose.
David N. Herrmann, MD, F�鶹��ýӳ��	Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acceleron. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint global. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Herrmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Herrmann has received intellectual property interests from a discovery or technology relating to health care.
Pierre Labauge, MD	Dr. Labauge has nothing to disclose.
Nathaniel M. Robbins, MD	Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Red Nucleus. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for TDG Health. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Jupiter Life Science Consulting. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Vaccine Injury Compensation Program. The institution of Dr. Robbins has received research support from Diamond Endowment Fund. The institution of Dr. Robbins has received research support from Reeves Endowment Fund. The institution of Dr. Robbins has received research support from Institute for Ethnomedicine. The institution of Dr. Robbins has received research support from Theravance. The institution of Dr. Robbins has received research support from Dysautonomia International. The institution of Dr. Robbins has received research support from National Institute of Health. The institution of Dr. Robbins has received research support from Vertex pharmaceutical. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as a Locums neurohospitalist with Hayes Locums. Dr. Robbins has received personal compensation in the range of $500-$4,999 for serving as a Speaker with The Dysautonomia Project.
Nicolas Collongues, MD	Nicolas Collongues, MD has nothing to disclose.
Stephen R. Deputy, MD	Dr. Deputy has nothing to disclose.
Aaron Tansy, MD	Dr. Tansy has received personal compensation for serving as an employee of PTC Therapeutics, Inc.. Dr. Tansy has stock in PTC Therapeutics, Inc..
Sang-Ahm Lee, MD	Dr. Lee has nothing to disclose.
Yann Hyvert, PhD	Dr. Hyvert has received personal compensation for serving as an employee of The healthcare business of Merck KGaA, Darmstadt, Germany. An immediate family member of Dr. Hyvert has received personal compensation for serving as an employee of The healthcare business of Merck KGaA, Darmstadt, Germany.
Miguel Angel Hernandez Perez	Miguel Angel Hernandez Perez has nothing to disclose.
Larisa Reyderman	Larisa Reyderman has nothing to disclose.
Souvik Dubey	Souvik Dubey has nothing to disclose.
Frank Diekstra, MD, PhD	No disclosure on file
Ahmad Ozair	Mr. Ozair has nothing to disclose.
Karissa Arca, MD	The institution of Dr. Arca has received research support from Miles for Migraine. Dr. Arca has received personal compensation in the range of $0-$499 for serving as a speaker with Miles for Migraine.
Tanya Bardakjian	Tanya Bardakjian has received personal compensation for serving as an employee of sarepta Therapeutics. Tanya Bardakjian has stock in Sarepta.
Nicolas Dubuisson, MD	Dr. Dubuisson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for ArgenX. The institution of Dr. Dubuisson has received research support from Le Fonds de la Recherche Scientifique (FNRS).
Jennifer Gewandter, PhD, MPH	No disclosure on file
Robert H. Dworkin, PhD	Robert H. Dworkin, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia, Akigai, Allay, AM-Pharma, Analgesic Solutions, Beckley, Biogen, Biosplice, Bsense, Cardialen, Chiesi, Clexio, Collegium, CombiGene, Confo, Contineum, Eccogene, Editas, Eli Lilly, Emmes, Endo, Epizon, Exicure, GlaxoSmithKline, Glenmark, Gloriana, JucaBio, Kriya, Mainstay, Merck, Mind Medicine, NeuroBo, Noema, OliPass, Orion, Oxford Cannabinoid Technologies, Pfizer, Q-State, Regenacy, Rho, Sangamo, Semnur, SIMR Biotech, Sinfonia, SK Biopharmaceuticals, Sparian, SPM Therapeutics, SPRIM Health, Tiefenbacher, Validae, Vertex, Viscera, and WCG.
Vikram Bhise, MD	Dr. Bhise has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharmaceuticals. The institution of Dr. Bhise has received research support from Horizon Blue Cross Blue Shield.
Giuseppe Lauria, MD	No disclosure on file
Ashhar Ali, DO, F�鶹��ýӳ��	Dr. Ali has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Ali has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Ebsco.
Rashmi Rao, MD	Dr. Rao has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Theranica. Dr. Rao has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Theranica. Dr. Rao has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for American Headache Society.
Masako Kinoshita, MD, PhD	Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka Pharmaceutical Co., Ltd.. Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai Co., Ltd.. Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Japan Co. Ltd. . Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichi Sankyo Company, Limited.. The institution of Dr. Kinoshita has received research support from Japan Society for the Promotion of Science. The institution of Dr. Kinoshita has received research support from Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering .
Noah A. Kolb, MD	Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abalone Medical. Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Disarm Therapeutics. Dr. Kolb has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisana corporation. Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NINDS. Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Locks Law. Dr. Kolb has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for walk up law office . Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for ralston, pope, diehl. The institution of Dr. Kolb has received research support from National Cancer Institute.
Yamin Sallowm, MD	Dr. Sallowm has nothing to disclose.
Amanda C. Peltier, MD, MS	Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for astrazeneca. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Csl Behring. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for alnylam. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for astrazeneca. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Goldman Ismail. The institution of Dr. Peltier has received research support from NIH. The institution of Dr. Peltier has received research support from CSL Behring.
Kurupath Radhakrishnan, MD, F�鶹��ýӳ��	No disclosure on file
Thomas L. Winder, PhD, FACMG	Dr. Winder has nothing to disclose.
Angel P. Sempere, MD	Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Adam M. Willis, MD	The institution of Dr. Willis has received research support from Air Force. Dr. Willis has received intellectual property interests from a discovery or technology relating to health care.
Gustavo Saposnik, MD	Dr. Saposnik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Saposnik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIHSS. The institution of Dr. Saposnik has received research support from Roche. The institution of Dr. Saposnik has received research support from Heart and Stroke Foundation of Canada.
Bertrand Bourre	Bertrand Bourre has nothing to disclose.
K. H. Vincent Lau, MD	Dr. Lau has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Lau has or had stock in Alnylam Pharmaceuticals.
Katherine L. Berry, MD	No disclosure on file
Kevin Bigaut	Kevin Bigaut has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Kevin Bigaut has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Peter Y. Van Den Bergh, MD, PhD, F�鶹��ýӳ��	Dr. Van den Bergh has nothing to disclose.
Aimee M. Aysenne, MD, MPH	Dr. Aysenne has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ceribell. Dr. Aysenne has received stock or an ownership interest from Teledoc. Dr. Aysenne has received stock or an ownership interest from Pfizer.
Gregory Krauss, MD	Dr. Krauss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle. Dr. Krauss has received stock or an ownership interest from EpiWatch.
Gabriel Torrealba Acosta, MD	Dr. Torrealba Acosta has nothing to disclose.
Ryan T. Brennan, DO	Dr. Brennan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Mikael Cohen	Mikael Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Roche, Merck, Ad scientiam, Novartis, Alexion, BMS.
Janak K. Nathan, MD	No disclosure on file
Hyojae Kim, MD	No disclosure on file
Jose Meca Lallana, MD	Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol-Myers-Squibb. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Meca Lallana has received research support from Merck. The institution of Dr. Meca Lallana has received research support from Novartis. The institution of Dr. Meca Lallana has received research support from Roche. The institution of Dr. Meca Lallana has received research support from Sanofi. The institution of Dr. Meca Lallana has received research support from Biogen.
Alfred Balasa, MD	Dr. Balasa has nothing to disclose.
Nikita Shukla, MD	The institution of Dr. Shukla has received research support from Roche.
Karla Licona, MD, MPH	Ms. Licona has nothing to disclose.
Arjumand Faruqi	No disclosure on file
Kristen Fisher, DO	Dr. Fisher has nothing to disclose.
Juliette Preston, MD	Dr. Preston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NFL. Dr. Preston has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck.
Kaoru Obata, MD	No disclosure on file
Jorge Maurino	Jorge Maurino has received personal compensation for serving as an employee of Roche Pharma Spain, Medical Department.
Kevin J. Kyle, MD	Dr. Kyle has nothing to disclose.
Casey R. Dunn, MD	No disclosure on file
Sam Hooshmand, DO	Dr. Hooshmand has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genetech USA. Dr. Hooshmand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics . Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech USA. Dr. Hooshmand has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Hooshmand has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics . Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen . The institution of Dr. Hooshmand has received research support from Novartis .
Derek G. Neupert, MD	No disclosure on file
Sean S. Zadeh, MD	Dr. Zadeh has nothing to disclose.
Nicky Wu, MD	No disclosure on file
Magdalena Stepien, MD	No disclosure on file
Tom Parry	Tom Parry has received personal compensation for serving as an employee of Ovid Therapeutics Inc. Tom Parry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingleheim. Tom Parry has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with NIH.
Lisa Knopf, MD	No disclosure on file
Xinran Xiang, MD	Dr. Xiang has nothing to disclose.
Rayaz A. Malik, MBBS, PhD	Prof. Malik has nothing to disclose.
Debasish Sanyal, MD, MBBS	No disclosure on file
Steve Bibu, MD	Dr. Bibu has nothing to disclose.

�鶹��ýӳ��

�鶹��ýӳ��